immatics biotechnologies GmbH Strategic Asset Allocation Index
immatics biotechnologies GmbH strategic asset allocation index. immatics biotechnologies GmbH (4A3) has a Strategic Asset Allocation Index of 19.2% as of June 2023. Strategic assets (PP&E of €41.94 Million plus long-term investments of €-) total €41.94 Million, measured against net assets of €218.21 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 4A3 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of immatics biotechnologies GmbH (2020–2022)
Strategic asset allocation index of immatics biotechnologies GmbH from 2020 to 2022. This chart shows how immatics biotechnologies GmbH's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the index stands at 19.2%, representing strategic assets of €41.94 Million against net assets of €218.21 Million EUR. Check immatics biotechnologies GmbH tangible equity quality to evaluate the tangible quality of the company's equity base.
immatics biotechnologies GmbH Strategic Asset Allocation Index by Year (2020–2022)
immatics biotechnologies GmbH strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for immatics biotechnologies GmbH from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see immatics biotechnologies GmbH (4A3) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 12.4% | €26.49 Million | €26.49 Million | €- | €213.16 Million | ▼ -72.7 pp |
| 2021 | 85.1% | €20.49 Million | €20.49 Million | €- | €24.06 Million | ▲ +71.7 pp |
| 2020 | 13.4% | €14.02 Million | €14.02 Million | €- | €104.26 Million | — |